Global Epigenetics Market 2014-2018

Global Epigenetics Market 2014-2018

Category : Pharmaceuticals
Published On : November  2013
Pages : 43



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio forecasts The Global Epigenetics Market 2014-2018 with a CAGR of 28.79 percent for the period 2013–2018. Several driving factors and trends will contribute to this growth—all of which will be outlined with detail in this report.  

TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors to provide the most accurate and detailed market research reports possible. 

A more specific breakdown of this report’s contents is below.

Overview of market share and landscape for the following key geographies:

• Americas
• EMEA
• APAC

Overview and impact analysis of:

• 3 Market Drivers
• 3 Market Challenges
• 3 Market Trends

Market Shares and SWOT Analysis for these vendors: 
• Celgene Corp.
• Eisai Inc.
• Merck & Co.
Five Force Model Impact Analysis of:

• Suppliers
• Buyers
• Substitutes
• New entrants 
• Market competition 

Note: All of the segments above are supplemented with a combination of statistical data, graphical analysis, and verbal explanation. 

After purchasing any of our reports, you can request a one hour meeting to discuss any questions you may have with our team of analysts.

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report


03.1 Market Overview

03.2 Product Offerings

03.3 Product Profile

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape


06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Mechanism of Action

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape


16.1 Competitive Scenario

16.1.1 Key News

16.1.2 Mergers and Acquisitions

16.2 Market Share Analysis 2013

17. Key Vendor Analysis

17.1 Celgene Corp.

17.1.1 Business Overview

17.1.2 Key Information

17.1.3 SWOT Analysis

17.2 Eisai Inc.

17.2.1 Business Overview

17.2.2 Key Information

17.2.3 SWOT Analysis

17.3 Merck & Co. Inc.

17.3.1 Business Overview

17.3.2 Business Segmentation

17.3.3 Key Information

17.3.4 SWOT Analysis

18. Other Reports in this Series

List of Exhibits


Exhibit 1: Market Research Methodology

Exhibit 2: Global Epigenetics Market 2013-2018 (US$ million)

Exhibit 3: Global Epigenetics Market Segmentation by Mechanism of Action

Exhibit 4: Business Segmentation of Merck & Co., Inc.


Enquiry Before Buy
image
Can´t read the image ? refresh here.